• DRAMP ID

    • DRAMP18066
    • Sequence

    • α helix
    • Sequence Name

    • MBI peptides as Omiganan(particularly MBI-226 and M
    • Description

    • analogues of indolicidin
    • Activity

    • Unknow
    • Medical use

    • acne and chronic nasal carrier of S. aureus
    • Stage of Development

    • Phase II(Failure)
    • Comments

    • failed to demonstrate their efficacy
    • Company

    • Migenix (Vancouver, BritishColumbia, Canada)
    • Target Organism

      • No MICs found on DRAMP database
    • Reference

      • Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.Eur J Clin Microbiol Infect Dis (2012)(PMID: 21964560)